Thermo Fisher Scientific Price Target Increased to $112.00 by Analysts at Cantor Fitzgerald (TMO)
Analysts at Cantor Fitzgerald increased their target price on shares of Thermo Fisher Scientific (NYSE:TMO) from $100.00 to $112.00 in a research report issued to clients and investors on Thursday, AmericanBankingNews.com reports. Cantor Fitzgerald’s price target would indicate a potential upside of 15.43% from the company’s current price.
A number of other analysts have also recently weighed in on TMO. Analysts at Goldman Sachs Group Inc. raised their price target on shares of Thermo Fisher Scientific from $89.00 to $94.00 in a research note to investors on Friday, September 27th. They now have a “neutral” rating on the stock. Separately, analysts at Mizuho raised their price target on shares of Thermo Fisher Scientific from $100.00 to $110.00 in a research note to investors on Tuesday, September 10th. They now have a “buy” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Thermo Fisher Scientific in a research note to investors on Thursday, September 5th. They now have a $95.00 price target on the stock. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $93.97.
Thermo Fisher Scientific (NYSE:TMO) traded down 0.46% on Thursday, hitting $97.03. The stock had a trading volume of 1,732,709 shares. Thermo Fisher Scientific has a 52 week low of $57.21 and a 52 week high of $92.72. The stock’s 50-day moving average is $90.87 and its 200-day moving average is $84.58. The company has a market cap of $34.981 billion and a price-to-earnings ratio of 27.62.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 23rd. The company reported $1.30 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.28 by $0.02. The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.18 billion. During the same quarter in the previous year, the company posted $1.19 earnings per share. The company’s revenue for the quarter was up 3.4% on a year-over-year basis.
Thermo Fisher Scientific Inc (NYSE:TMO) is engaged in serving science.